Showing results (41-50 of 105) with videos related to
Sort By:
Pageof 11
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 27, 2007
Deposition-associated diseases related with a monoclonal compoundM J Molina-Garrido, C Guillén-Ponce, A Mora, et al.Anales De Medicina Interna (Madrid, Spain : 1984)|June 19, 2008
[Systemic mastocytosis: systematic review]M J Molina-Garrido, A Mora, C Guillén-Ponce, et al.Journal of Epidemiology and Community Health|February 3, 2000
Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study GroupM Porta, N Malats, L Guarner, et al.European Journal of Cancer Care|January 22, 2010
Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumoursA López-Pousa, J Rifà, A Casas de Tejerina, et al.The American Journal of Pathology|February 1, 1989
Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systemsP Garin-Chesa, H R Beresford, A Carrato-Mena, et al.Journal of Gastrointestinal Cancer|May 15, 2015
A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and CostsA Carrato, A Falcone, M Ducreux, et al.American Journal of Clinical Oncology|February 1, 1992
A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.)E Díaz-Rubio, J Jimeno, A Antón, et al.Lung Cancer (Amsterdam, Netherlands)|March 16, 2000
Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancerJ A Sacristán, T Kennedy-Martin, R Rosell, et al.The Annals of Occupational Hygiene|August 10, 2000
Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study GroupJ Alguacil, T Kauppinen, M Porta, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II studyE Felip, R Rosell, M Domine, et al.Pageof 11